Radcliffe Capital Management’s SeaStar Medical Holding Corp Warrant ICUCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-243,106
Closed -$8.21K 479
2023
Q2
$8.21K Hold
243,106
﹤0.01% 445
2023
Q1
$19.2K Hold
243,106
﹤0.01% 434
2022
Q4
$997K Sell
243,106
-6,894
-3% -$687 0.03% 692
2022
Q3
$2.57M Hold
250,000
0.06% 527
2022
Q2
$2.54M Hold
250,000
0.06% 549
2022
Q1
$2.53M Hold
250,000
0.06% 526
2021
Q4
$2.51M Hold
250,000
0.07% 447
2021
Q3
$2.51M Hold
250,000
0.07% 383
2021
Q2
$2.48M Hold
250,000
0.08% 403
2021
Q1
$2.45M Buy
+250,000
New +$102K 0.1% 363

Other funds holding ICUCW

Radcliffe Capital Management's ICUCW Position: Q3 2023 in Review

Radcliffe Capital Management sold out of SeaStar Medical Holding Corp Warrant (ICUCW) in Q3 2023, closing a stake of 243,106 shares — an estimated $8.21K sold.

Radcliffe Capital Management first reported a position in ICUCW in Q1 2021 and held it in 10 quarters. The position peaked at $2.57M in Q3 2022. 30 funds tracked by Wall St. Rank hold ICUCW as of Q3 2023.

  • Radcliffe Capital Management reported no remaining SeaStar Medical Holding Corp Warrant position as of Q3 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 243,106 SeaStar Medical Holding Corp Warrant shares in Q3 2023, an estimated $8.21K.
  • Radcliffe Capital Management first reported a position in SeaStar Medical Holding Corp Warrant in Q1 2021 and held it in 10 quarters.
  • Radcliffe Capital Management's SeaStar Medical Holding Corp Warrant position peaked at $2.57M in Q3 2022.
  • 30 funds tracked by Wall St. Rank held SeaStar Medical Holding Corp Warrant as of Q3 2023.

Based on Radcliffe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.